LifeMD grants GC Eric Yecies 375,000 restricted shares with performance milestones

LifeMD, Inc.

375,000 restricted shares granted; replaces 200,000 stock options ($7.55 strike) and 105,000 performance units cancelled.
150,000 shares time-vest: 12,500 immediately, 37,500 Nov 20, 2023, 100,000 Jan 1, 2024.
225,000 performance shares: $100M net revenue/5% EBITDA margin by 2025; $150M/10% by 2026; $200M/10% by 2027.
75,000 shares vest by CEO/Board discretion for 2023 and 2024 performance on 3/1/24 and 3/1/25.
Unvested shares accelerate upon change of control or termination without cause/good reason.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.